Noopept (GVS-111)

Noopept (GVS-111) is a synthetic dipeptide developed in Russia in the 1990s as part of research into racetam-like cognitive enhancers. Unlike true racetams, noopept is derived from the neuropeptide cycloprolylglycine and requires much smaller doses — typically 10-30mg compared to piracetam's 1-3 gram range [1]. Russian researchers designed it specifically to cross the blood-brain barrier more efficiently than earlier nootropics.\n\nToday, people use noopept primarily for memory consolidation and mild cognitive enhancement during study or work sessions. It's become popular in the nootropics community as a "daily driver" — something you can take regularly without building significant tolerance. Unlike stimulants, noopept doesn't provide immediate energy but rather subtle improvements in information processing and recall that become apparent over 30-60 minutes.\n\nThe compound remains unscheduled in most countries and is widely available through nootropics suppliers. Quality varies significantly between vendors, making source selection critical for consistent effects.